Ann Meulemans

Direttore/Membro del Consiglio presso Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Ann Meulemans

Società	Posizione	Inizio	Fine
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium.	Direttore/Membro del Consiglio	15/05/2020	-

Società	Posizione	Inizio	Fine
OCTIMET Oncology NV OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands.	Fondatore	01/01/2016	-
Movetis NV Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.	Corporate Officer/Principal	01/01/2007	-

University of Antwerp

Doctorate Degree

Distribuzione geografica

Belgio

Posizioni

Corporate Officer/Principal	1
Doctorate Degree	1
Graduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
Movetis NV Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium.	Health Technology
OCTIMET Oncology NV OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands.	Health Technology
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium.	Commercial Services